renamed Structure Therapeutics in 2021) Origin Story: Founded by Raymond Stevens, PhD, a structural biologist renowned for his work decoding G protein-coupled receptor (GPCR) structures
The review delves into the intricacies of different modification approaches, including N and C-terminal modifications, Fatty acid Side chain Modifications, and Large Molecule Conjugation Modifications, highlighting their rationale and resulting improvements in half-life, stability, receptor binding, and bioactivity
Cholesterol panels look completely different
Young recalls that the moment he looked at Eng's results of some tests of exendin-4 in diabetic mice, he realised it could be a drug (Winkler, Cohen)
While it promotes some weight loss, it is not indicated for that purpose